熱門資訊> 正文
Movano Health获得纳斯达克批准上市延期
2025-08-29 04:44
- Movano Health (NASDAQ:MOVE) on Thursday said it received a listing extension from the Nasdaq Hearings Panel on August 27, 2025.
- Extension requires compliance with Listing Rule 5250(c)(1) by filing Q1 and Q2 2025 10-Qs by September 30, 2025.
- Must also comply with Listing Rule 5550(a)(2) requiring the maintenance of $1.00 per share bid price, on or before October 30, 2025.
- Panel decision follows August 19, 2025 hearing reviewing company's compliance plan.
- Additionally, on August 19, 2025, the company filed a Preliminary Proxy Statement for its Annual Shareholders Meeting to be held on September 26, 2025, at which the company's shareholders will have the opportunity to approve a reverse stock split proposal, the effect of which will allow the company to demonstrate compliance rule within the extension period granted by the panel.
- MOVE +17.61% after hours to $0.7264
- Source: Press Release
More on Movano
- Seeking Alpha’s Quant Rating on Movano
- Historical earnings data for Movano
- Financial information for Movano
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。